IFN-Alpha Kinoid: A Promising Vaccine against Type 1 Diabetes Targeting IFN-alpha in NOD Mice

被引：0
|
作者：
Caillot, Noemie
Colaone, Fabien
Bertrand, Romain
Da Silva, Jennifer
Hamdi, Samir
Bonnefoy, Jonathan
Lehuen, Agnes
Boitard, Boitard F.
Grouard-Vogel, Geraldine
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1190-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1190-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IFNα kinoid is a promising vaccine against type 1 diabetes targeting IFNα in the NOD mouse model
    Caillot, N.
    Colaone, F.
    Bertrand, R.
    Da Silva, J.
    Hamdi, S.
    Bonnefoy, J.
    Serra, V.
    Lehuen, A.
    Boitard, C.
    Grouard-Vogel, G.
    DIABETOLOGIA, 2019, 62 : S7 - S7
  • [2] Ingested IFN-alpha suppresses IDDM in NOD mice
    Nelson, L
    Malone, M
    Darcan, S
    Papolla, M
    Brod, SA
    FASEB JOURNAL, 1998, 12 (04): : A600 - A600
  • [3] Oral IFN-alpha delays IDDM in NOD mice.
    Brod, S
    Foote, B
    Darcan, S
    Papolla, M
    Nelson, L
    DIABETES, 1997, 46 : 623 - 623
  • [4] RECOMBINANT IFN-ALPHA IN LYMPHOMAS
    ZIEGLERHEITBROCK, HW
    THIEL, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S213 - S215
  • [5] Three-dimensional models of interferon-alpha subtypes IFN-con1, IFN-alpha(8), and IFN-alpha(1), derived from the crystal structure of IFN-alpha(2b)
    Walter, MR
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 952 - 962
  • [6] Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha 1 and IFN-alpha 2
    Liptakova, H
    Kontsekova, E
    Alcami, A
    Smith, GL
    Kontsek, P
    VIROLOGY, 1997, 232 (01) : 86 - 90
  • [7] THE IMMUNOMODULATORY ROLE OF IFN-ALPHA OR MALTOSE-STABILIZED IFN-ALPHA ON T-CELL ACTIVATION
    KOHNO, K
    HOLAN, V
    MATSUDA, S
    KURIMOTO, M
    MINOWADA, J
    LYMPHOKINE AND CYTOKINE RESEARCH, 1992, 11 (04): : 221 - 227
  • [8] Maintenance therapy with interferon-alpha (IFN-alpha) versus IFN-alpha plus chemotherapy in multiple myeloma (MM)
    Zervas, K
    Pouli, A
    Perifanis, V
    Papanastasiou, K
    Chatziyianni, M
    Mitsouli, C
    Maniatis, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (02) : 142 - 148
  • [9] ON THE CLINICAL USE OF IFN-ALPHA VARIANTS
    KANDEFERSZERSZEN, M
    ANDERSSON, G
    EKRE, HP
    LUNDGREN, E
    ANTICANCER RESEARCH, 1988, 8 (05) : 1143 - 1143
  • [10] In vitro treatment of CML progenitors with IFN-alpha has no direct correlation with the clinical outcome of IFN-alpha treatment
    Stromberg, O
    Pisa, P
    Hansson, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1048 - 1048
12345